# A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Diffuse Glioma

> **NCT05622409** · — · RECRUITING · sponsor: **National Health Research Institutes, Taiwan** · enrollment: 250 (estimated)

## Conditions studied

- Primary Malignant Brain Tumors

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05622409
- **Lead sponsor:** National Health Research Institutes, Taiwan
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-29
- **Primary completion:** 2025-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2025-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05622409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05622409, "A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Diffuse Glioma". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT05622409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*